Pyxis Oncology Stock - Thursday technicals around key trading levels
18.06.2026 - 17:43:57 | ad-hoc-news.de
Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:40 CET. Details in the imprint.
Pyxis Oncology (US70611B1026) is trading in the low single digits on Nasdaq, with no new company filings or major news reported today by primary outlets such as Reuters or the company’s own investor-relations page. Thursday’s lens therefore falls on chart levels and recent trading behavior.
Background and price data on Pyxis Oncology
Key figures, filings and older news on Pyxis Oncology stock can be found via the ad hoc news dossier and the company’s investor-relations pages.
What the latest quote shows
According to MarketBeat, Pyxis Oncology shares closed at $1.90 on Nasdaq on 06/17/2026, up 0.15 dollars or 8.57% on the day.
The same data show an extended-hours indication at $1.85, 2.42% below the regular close, with limited pre-market liquidity reported.
Thursday’s chart and volatility focus
With no fresh earnings or regulatory headlines, Thursday attention centers on volatility, trading range and key technical reference points, such as recent highs and lows, rather than on new fundamental information.
Over recent months, Pyxis Oncology shares have fluctuated in a relatively wide band in percentage terms, typical for early-stage biotech names trading at low absolute price levels.
How technical levels frame the stock
On many charting platforms, the stock’s recent history shows swings of several percentage points within short time frames, underscoring a risk profile in line with other small-cap oncology developers.
Against this backdrop, chart watchers often pay attention to simple moving averages and prior support zones, even though such technical markers are only one input alongside clinical and funding news.
The product behind the stock
Pyxis Oncology focuses on developing immuno-oncology drug candidates designed to harness the immune system against cancer, with a pipeline of antibody-based therapies described in company materials. Detailed overviews are provided on the firm’s own website and IR documents.
Where the stock trades today
The shares of Pyxis Oncology (US70611B1026) most recently traded on Nasdaq at $1.90 as of 06/17/2026, 04:00 PM Eastern Time.
Key facts on Pyxis Oncology stock
- Company: Pyxis Oncology Inc.
- ISIN: US70611B1026
- WKN: A3C6R8
- Ticker: PYXS
- Venue: Nasdaq
- Price (as of 06/17/2026, 16:00 Eastern Time): 1.90 USD
- Market cap: around 120 million USD (as of 06/17/2026, based on Nasdaq data and latest share count)
- Sector / Industry: Health Care / Biotechnology
- Index membership: not a constituent of major benchmarks such as the S&P 500 or Nasdaq-100
- Next earnings date: not officially scheduled on the company’s investor-relations calendar
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
